The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[2-(Biphenyl-4-ylamino)-1-phosphono-ethyl]-phosphonic acid ID: ALA382291
PubChem CID: 5277496
Max Phase: Preclinical
Molecular Formula: C14H17NO6P2
Molecular Weight: 357.24
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=P(O)(O)C(CNc1ccc(-c2ccccc2)cc1)P(=O)(O)O
Standard InChI: InChI=1S/C14H17NO6P2/c16-22(17,18)14(23(19,20)21)10-15-13-8-6-12(7-9-13)11-4-2-1-3-5-11/h1-9,14-15H,10H2,(H2,16,17,18)(H2,19,20,21)
Standard InChI Key: IVYDRBXYBXGECK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
6.9951 2.2407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1655 2.2354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7634 1.5234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1771 0.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0056 0.8170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4124 1.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6517 0.8350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4788 0.8400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8867 1.5582 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
9.8977 0.1326 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
10.3165 -0.5843 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2940 2.2792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6090 1.1485 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1645 1.9691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6135 0.5535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1820 -0.2872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2353 1.5430 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9343 1.5179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5181 2.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6917 2.2192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2848 1.5028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7019 0.7950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5268 0.8001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 12 2 0
6 1 1 0
9 13 1 0
1 2 2 0
9 14 1 0
3 4 2 0
10 15 1 0
7 8 1 0
10 16 1 0
7 17 1 0
17 6 1 0
8 9 1 0
4 5 1 0
18 19 2 0
8 10 1 0
19 20 1 0
2 3 1 0
20 21 2 0
10 11 2 0
21 22 1 0
5 6 2 0
22 23 2 0
23 18 1 0
3 18 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.24Molecular Weight (Monoisotopic): 357.0531AlogP: 2.45#Rotatable Bonds: 6Polar Surface Area: 127.09Molecular Species: ACIDHBA: 3HBD: 5#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 0.86CX Basic pKa: 4.85CX LogP: -0.55CX LogD: -3.94Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.50Np Likeness Score: -0.30
References 1. Kotsikorou E, Song Y, Chan JM, Faelens S, Tovian Z, Broderick E, Bakalara N, Docampo R, Oldfield E.. (2005) Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase., 48 (19): [PMID:16162013 ] [10.1021/jm058220g ] 2. Song Y, Chan JM, Tovian Z, Secrest A, Nagy E, Krysiak K, Bergan K, Parniak MA, Oldfield E.. (2008) Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation., 16 (19): [PMID:18789701 ] [10.1016/j.bmc.2008.08.047 ]